Wholesale of pharmaceutical and medical goods
FOCUS PHARMA AS
Revenue 2024
NOK 1.3m
Operating profit
NOK 124,000
Equity
NOK −717,000
Incorporated
2002
Share capital
NOK 100,000
Key figures · 2024
Current ratio
0.31
Equity ratio
-104.0%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 9.9% | |
| Net margin (%%) | 4.0% | |
| Return on assets (%%) | 17.9% | |
| Likviditet | ||
| Current ratio | 0.31 | |
| Working capital | −967k | |
| Soliditet | ||
| Equity ratio (%%) | -104.0% | |
| Debt-to-equity ratio | -1.96 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.